• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Retrospective observational analysis of hospital discharge database to characterize primary pulmonary hypertension and its outcomes in Spain from 2004 to 2015.对医院出院数据库进行回顾性观察分析,以描述2004年至2015年西班牙原发性肺动脉高压及其转归情况。
Medicine (Baltimore). 2019 May;98(18):e15518. doi: 10.1097/MD.0000000000015518.
2
Influence of COPD on outcomes of patients hospitalized with heart failure: Analysis of the Spanish National Hospital Discharge Database (2001-2015).COPD 对心力衰竭住院患者结局的影响:西班牙全国住院患者数据库分析(2001-2015 年)。
Int J Cardiol. 2018 Oct 15;269:213-219. doi: 10.1016/j.ijcard.2018.07.067. Epub 2018 Jul 17.
3
Comorbidities and risk of mortality among hospitalized patients with idiopathic pulmonary fibrosis in Spain from 2002 to 2014.2002 年至 2014 年期间西班牙特发性肺纤维化住院患者的合并症与死亡率风险。
Respir Med. 2018 May;138:137-143. doi: 10.1016/j.rmed.2018.04.005. Epub 2018 Apr 11.
4
Time trends in incidence and outcomes of hospitalizations for aspiration pneumonia among elderly people in Spain (2003-2013).西班牙老年人吸入性肺炎住院发病率及转归的时间趋势(2003 - 2013年)
Eur J Intern Med. 2017 Mar;38:61-67. doi: 10.1016/j.ejim.2016.12.022. Epub 2017 Jan 5.
5
Trends in incidence and outcomes of revision total hip arthroplasty in Spain: a population based study.西班牙翻修全髋关节置换术的发病率和结局趋势:一项基于人群的研究。
BMC Musculoskelet Disord. 2012 Mar 19;13:37. doi: 10.1186/1471-2474-13-37.
6
Chronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. An observational study using hospital discharge data in Spain (2004-2013).慢性阻塞性肺疾病预示着心房颤动的更高发病率和住院死亡率。一项利用西班牙医院出院数据(2004 - 2013年)的观察性研究。
Int J Cardiol. 2017 Jun 1;236:209-215. doi: 10.1016/j.ijcard.2017.02.017. Epub 2017 Feb 7.
7
National trends and outcomes of hospitalizations for pulmonary hypertension in Spain (2001-2014).西班牙肺动脉高压住院患者的全国趋势和结局(2001-2014 年)。
Int J Cardiol. 2018 Jul 15;263:125-131. doi: 10.1016/j.ijcard.2018.04.026. Epub 2018 Apr 7.
8
Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data.利用行政数据对西班牙特发性肺纤维化住院趋势进行的回顾性观察研究(2004 - 2013年)
BMJ Open. 2017 Feb 13;7(2):e013156. doi: 10.1136/bmjopen-2016-013156.
9
Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012).2型糖尿病患者和非糖尿病患者缺血性卒中的时间趋势:西班牙国家医院出院数据(2003 - 2012年)分析
PLoS One. 2015 Dec 29;10(12):e0145535. doi: 10.1371/journal.pone.0145535. eCollection 2015.
10
Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013).支气管扩张症住院情况的时间趋势:对西班牙国家医院出院数据(2004年至2013年)的分析
PLoS One. 2016 Sep 13;11(9):e0162282. doi: 10.1371/journal.pone.0162282. eCollection 2016.

引用本文的文献

1
Hospitalizations and In-Hospital Fatality Among Influenza Patients in the Pre-Pandemic and COVID-19 Pandemic Periods.大流行前和新冠疫情期间流感患者的住院情况及院内死亡率
J Clin Med. 2025 Mar 7;14(6):1785. doi: 10.3390/jcm14061785.
2
Hospital outcomes for patients with pulmonary arterial hypertension in sepsis and septic shock.脓毒症和感染性休克患者的肺动脉高压的医院转归。
BMC Pulm Med. 2022 Oct 3;22(1):374. doi: 10.1186/s12890-022-02145-1.
3
Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases.在大型管理数据库中评估基于编码的算法以识别肺动脉高压和慢性血栓栓塞性肺动脉高压患者。
Pulm Circ. 2020 Nov 10;10(4):2045894020961713. doi: 10.1177/2045894020961713. eCollection 2020 Oct-Dec.

本文引用的文献

1
Advances in medical therapy for pulmonary arterial hypertension.肺动脉高压的医学治疗进展。
Curr Opin Cardiol. 2019 Jan;34(1):98-103. doi: 10.1097/HCO.0000000000000583.
2
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project.特发性肺动脉高压诊断前的高医疗利用率支持早期诊断算法的可行性:SPHInX项目。
Pulm Circ. 2018 Oct-Dec;8(4):2045894018798613. doi: 10.1177/2045894018798613.
3
Age, risk and outcomes in idiopathic pulmonary arterial hypertension.特发性肺动脉高压的年龄、风险与预后
Eur Respir J. 2018 May 3;51(5). doi: 10.1183/13993003.00629-2018. Print 2018 May.
4
National trends and outcomes of hospitalizations for pulmonary hypertension in Spain (2001-2014).西班牙肺动脉高压住院患者的全国趋势和结局(2001-2014 年)。
Int J Cardiol. 2018 Jul 15;263:125-131. doi: 10.1016/j.ijcard.2018.04.026. Epub 2018 Apr 7.
5
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension.年龄和合并症对特发性肺动脉高压危险分层的影响。
Eur Respir J. 2018 May 3;51(5). doi: 10.1183/13993003.02310-2017. Print 2018 May.
6
Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population.美国的肺动脉高压:一项针对大量参保儿童人群的流行病学研究。
Pulm Circ. 2017 Feb 1;7(1):126-136. doi: 10.1086/690007. eCollection 2017 Mar.
7
Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre.30 年期间肺动脉高压的趋势:来自单一转诊中心的经验
Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):915-923. doi: 10.1016/j.rec.2016.12.044. Epub 2017 Apr 26.
8
Nationwide trends in inpatient admissions of pulmonary hypertension in the United States from 2000 to 2013.2000年至2013年美国肺动脉高压住院患者的全国性趋势。
Adv Respir Med. 2017;85(2):77-86. doi: 10.5603/ARM.2017.0014.
9
Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012.美国肺动脉高压相关住院治疗的趋势与结果:对2001年至2012年全国住院患者样本数据库的分析
JAMA Cardiol. 2016 Dec 1;1(9):1021-1029. doi: 10.1001/jamacardio.2016.3591.
10
Beast of Pulmonary Arterial Hypertension Burden.肺动脉高压负担之痛
JAMA Cardiol. 2016 Dec 1;1(9):1030-1031. doi: 10.1001/jamacardio.2016.3829.

对医院出院数据库进行回顾性观察分析,以描述2004年至2015年西班牙原发性肺动脉高压及其转归情况。

Retrospective observational analysis of hospital discharge database to characterize primary pulmonary hypertension and its outcomes in Spain from 2004 to 2015.

作者信息

de-Miguel-Díez Javier, Lopez-de-Andres Ana, Hernandez-Barrera Valentin, Jimenez-Trujillo Isabel, Mendez-Bailon Manuel, de Miguel-Yanes Jose M, Muñoz-Rivas Nuria, Romero-Maroto Martin, Jimenez-Garcia Rodrigo

机构信息

Respiratory Department, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM).

Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorcón.

出版信息

Medicine (Baltimore). 2019 May;98(18):e15518. doi: 10.1097/MD.0000000000015518.

DOI:10.1097/MD.0000000000015518
PMID:31045844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6504269/
Abstract

To examine trends in the incidence, characteristics and outcomes, and to identify factors associated with in-hospital mortality (IHM) of patients hospitalized for primary pulmonary hypertension (PPH) in Spain (2004-2015).We included all patients hospitalized with PPH and included in the Spanish National Hospital Discharge Database.We analyzed 46,883 discharges of patients (7.14% with PPH as their primary diagnosis). Incidence rates decreased from 6.15 cases per 100,000 inhabitants in 2004-06 to 3.40 in 2013-15 (P < .001). Mean age rose from 66.43 ± 21.28 to 69.73 ± 21.12 years (P < .001) and the proportion of females increased over the study period (58.44% vs 60.71%; P < .001). Comorbidity using the Charlson Comorbidity Index (CCI) also increased with 16.07% having CCI ≥3 in 2004-06 vs 21.795 in 2013-15. Median length of hospital stay (LOHS) was 1 day longer in period 2004-06, than in 2013-15 (9 vs 8 days; P < .001). The proportion of patients who were considered a readmission and the mean costs increased from 15.7% and 3712.46&OV0556; in the first period to 17.14% and 4040.28&OV0556; in 2013-15 (P < .001). IHM increased from 8.2% in 2004-06 to 9.93% in 2013-15 (P < .001). The predictors' of IHM among PPH patients included comorbidity and use of mechanical ventilation. Primary diagnosis of PPH did not predict higher IHM (OR 1.07; 95%CI 09-1.26).Our data indicates that the incidence of hospitalizations decreased in Spain between 2004 and 2015. Parallel, LOHS also decreased during this period. By contrast, comorbidity increased over time in PPH patients, as well as readmission rates, costs and IHM.

摘要

为研究西班牙原发性肺动脉高压(PPH)住院患者的发病率、特征及转归趋势,并确定与院内死亡率(IHM)相关的因素。我们纳入了西班牙国家医院出院数据库中所有因PPH住院的患者。我们分析了46883例患者的出院情况(7.14%以PPH作为主要诊断)。发病率从2004 - 2006年的每10万居民6.15例降至2013 - 2015年的3.40例(P < 0.001)。平均年龄从66.43±21.28岁升至69.73±21.12岁(P < 0.001),且研究期间女性比例增加(58.44%对60.71%;P < 0.001)。使用Charlson合并症指数(CCI)的合并症情况也有所增加,2004 - 2006年CCI≥3的患者为16.07%,而2013 - 2015年为21.795%。2004 - 2006年的中位住院时间(LOHS)比2013 - 2015年长1天(9天对8天;P < 0.001)。再次入院患者的比例及平均费用从第一阶段的15.7%和3712.46欧元增至2013 - 2015年的17.14%和4040.28欧元(P < 0.001)。IHM从2004 - 2006年的8.2%增至2013 - 2015年的9.93%(P < 0.001)。PPH患者中IHM的预测因素包括合并症和机械通气的使用。PPH的主要诊断并不能预测更高的IHM(比值比1.07;95%置信区间0.9 - 1.26)。我们的数据表明,2004年至2015年西班牙住院率下降。与此同时,在此期间LOHS也下降。相比之下,PPH患者的合并症、再入院率、费用及IHM随时间增加。